Subnational mapping of under-5 and neonatal mortality trends in India: the Global Burden of Disease Study 2000-17.
Journal
Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R
Informations de publication
Date de publication:
23 05 2020
23 05 2020
Historique:
received:
30
09
2019
revised:
19
02
2020
accepted:
24
02
2020
pubmed:
16
5
2020
medline:
11
6
2020
entrez:
16
5
2020
Statut:
ppublish
Résumé
India has made substantial progress in improving child survival over the past few decades, but a comprehensive understanding of child mortality trends at disaggregated geographical levels is not available. We present a detailed analysis of subnational trends of child mortality to inform efforts aimed at meeting the India National Health Policy (NHP) and Sustainable Development Goal (SDG) targets for child mortality. We assessed the under-5 mortality rate (U5MR) and neonatal mortality rate (NMR) from 2000 to 2017 in 5 × 5 km grids across India, and for the districts and states of India, using all accessible data from various sources including surveys with subnational geographical information. The 31 states and groups of union territories were categorised into three groups using their Socio-demographic Index (SDI) level, calculated as part of the Global Burden of Diseases, Injuries, and Risk Factors Study on the basis of per-capita income, mean education, and total fertility rate in women younger than 25 years. Inequality between districts within the states was assessed using the coefficient of variation. We projected U5MR and NMR for the states and districts up to 2025 and 2030 on the basis of the trends from 2000 to 2017 and compared these projections with the NHP 2025 and SDG 2030 targets for U5MR (23 deaths and 25 deaths per 1000 livebirths, respectively) and NMR (16 deaths and 12 deaths per 1000 livebirths, respectively). We assessed the causes of child death and the contribution of risk factors to child deaths at the state level. U5MR in India decreased from 83·1 (95% uncertainty interval [UI] 76·7-90·1) in 2000 to 42·4 (36·5-50·0) per 1000 livebirths in 2017, and NMR from 38·0 (34·2-41·6) to 23·5 (20·1-27·8) per 1000 livebirths. U5MR varied 5·7 times between the states of India and 10·5 times between the 723 districts of India in 2017, whereas NMR varied 4·5 times and 8·0 times, respectively. In the low SDI states, 275 (88%) districts had a U5MR of 40 or more per 1000 livebirths and 291 (93%) districts had an NMR of 20 or more per 1000 livebirths in 2017. The annual rate of change from 2010 to 2017 varied among the districts from a 9·02% (95% UI 6·30-11·63) reduction to no significant change for U5MR and from an 8·05% (95% UI 5·34-10·74) reduction to no significant change for NMR. Inequality between districts within the states increased from 2000 to 2017 in 23 of the 31 states for U5MR and in 24 states for NMR, with the largest increases in Odisha and Assam among the low SDI states. If the trends observed up to 2017 were to continue, India would meet the SDG 2030 U5MR target but not the SDG 2030 NMR target or either of the NHP 2025 targets. To reach the SDG 2030 targets individually, 246 (34%) districts for U5MR and 430 (59%) districts for NMR would need a higher rate of improvement than they had up to 2017. For all major causes of under-5 death in India, the death rate decreased between 2000 and 2017, with the highest decline for infectious diseases, intermediate decline for neonatal disorders, and the smallest decline for congenital birth defects, although the magnitude of decline varied widely between the states. Child and maternal malnutrition was the predominant risk factor, to which 68·2% (65·8-70·7) of under-5 deaths and 83·0% (80·6-85·0) of neonatal deaths in India could be attributed in 2017; 10·8% (9·1-12·4) of under-5 deaths could be attributed to unsafe water and sanitation and 8·8% (7·0-10·3) to air pollution. India has made gains in child survival, but there are substantial variations between the states in the magnitude and rate of decline in mortality, and even higher variations between the districts of India. Inequality between districts within states has increased for the majority of the states. The district-level trends presented here can provide crucial guidance for targeted efforts needed in India to reduce child mortality to meet the Indian and global child survival targets. District-level mortality trends along with state-level trends in causes of under-5 and neonatal death and the risk factors in this Article provide a comprehensive reference for further planning of child mortality reduction in India. Bill & Melinda Gates Foundation; and Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare, Government of India.
Sections du résumé
BACKGROUND
India has made substantial progress in improving child survival over the past few decades, but a comprehensive understanding of child mortality trends at disaggregated geographical levels is not available. We present a detailed analysis of subnational trends of child mortality to inform efforts aimed at meeting the India National Health Policy (NHP) and Sustainable Development Goal (SDG) targets for child mortality.
METHODS
We assessed the under-5 mortality rate (U5MR) and neonatal mortality rate (NMR) from 2000 to 2017 in 5 × 5 km grids across India, and for the districts and states of India, using all accessible data from various sources including surveys with subnational geographical information. The 31 states and groups of union territories were categorised into three groups using their Socio-demographic Index (SDI) level, calculated as part of the Global Burden of Diseases, Injuries, and Risk Factors Study on the basis of per-capita income, mean education, and total fertility rate in women younger than 25 years. Inequality between districts within the states was assessed using the coefficient of variation. We projected U5MR and NMR for the states and districts up to 2025 and 2030 on the basis of the trends from 2000 to 2017 and compared these projections with the NHP 2025 and SDG 2030 targets for U5MR (23 deaths and 25 deaths per 1000 livebirths, respectively) and NMR (16 deaths and 12 deaths per 1000 livebirths, respectively). We assessed the causes of child death and the contribution of risk factors to child deaths at the state level.
FINDINGS
U5MR in India decreased from 83·1 (95% uncertainty interval [UI] 76·7-90·1) in 2000 to 42·4 (36·5-50·0) per 1000 livebirths in 2017, and NMR from 38·0 (34·2-41·6) to 23·5 (20·1-27·8) per 1000 livebirths. U5MR varied 5·7 times between the states of India and 10·5 times between the 723 districts of India in 2017, whereas NMR varied 4·5 times and 8·0 times, respectively. In the low SDI states, 275 (88%) districts had a U5MR of 40 or more per 1000 livebirths and 291 (93%) districts had an NMR of 20 or more per 1000 livebirths in 2017. The annual rate of change from 2010 to 2017 varied among the districts from a 9·02% (95% UI 6·30-11·63) reduction to no significant change for U5MR and from an 8·05% (95% UI 5·34-10·74) reduction to no significant change for NMR. Inequality between districts within the states increased from 2000 to 2017 in 23 of the 31 states for U5MR and in 24 states for NMR, with the largest increases in Odisha and Assam among the low SDI states. If the trends observed up to 2017 were to continue, India would meet the SDG 2030 U5MR target but not the SDG 2030 NMR target or either of the NHP 2025 targets. To reach the SDG 2030 targets individually, 246 (34%) districts for U5MR and 430 (59%) districts for NMR would need a higher rate of improvement than they had up to 2017. For all major causes of under-5 death in India, the death rate decreased between 2000 and 2017, with the highest decline for infectious diseases, intermediate decline for neonatal disorders, and the smallest decline for congenital birth defects, although the magnitude of decline varied widely between the states. Child and maternal malnutrition was the predominant risk factor, to which 68·2% (65·8-70·7) of under-5 deaths and 83·0% (80·6-85·0) of neonatal deaths in India could be attributed in 2017; 10·8% (9·1-12·4) of under-5 deaths could be attributed to unsafe water and sanitation and 8·8% (7·0-10·3) to air pollution.
INTERPRETATION
India has made gains in child survival, but there are substantial variations between the states in the magnitude and rate of decline in mortality, and even higher variations between the districts of India. Inequality between districts within states has increased for the majority of the states. The district-level trends presented here can provide crucial guidance for targeted efforts needed in India to reduce child mortality to meet the Indian and global child survival targets. District-level mortality trends along with state-level trends in causes of under-5 and neonatal death and the risk factors in this Article provide a comprehensive reference for further planning of child mortality reduction in India.
FUNDING
Bill & Melinda Gates Foundation; and Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare, Government of India.
Identifiants
pubmed: 32413293
pii: S0140-6736(20)30471-2
doi: 10.1016/S0140-6736(20)30471-2
pmc: PMC7262604
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1640-1658Investigateurs
Rakhi Dandona
(R)
G Anil Kumar
(GA)
Nathaniel J Henry
(NJ)
Vasna Joshua
(V)
Siddarth Ramji
(S)
Subodh S Gupta
(SS)
Deepti Agrawal
(D)
Rashmi Kumar
(R)
Rakesh Lodha
(R)
Matthews Mathai
(M)
Nicholas J Kassebaum
(NJ)
Anamika Pandey
(A)
Haidong Wang
(H)
Anju Sinha
(A)
Rajkumar Hemalatha
(R)
Rizwan S Abdulkader
(RS)
Vivek Agarwal
(V)
Sandra Albert
(S)
Atanu Biswas
(A)
Roy Burstein
(R)
Joy K Chakma
(JK)
D J Christopher
(DJ)
Michael Collison
(M)
A P Dash
(AP)
Sagnik Dey
(S)
Daniel Dicker
(D)
William Gardner
(W)
Scott D Glenn
(SD)
Mahaveer J Golechha
(MJ)
Yihua He
(Y)
Suparna G Jerath
(SG)
Rajni Kant
(R)
Anita Kar
(A)
Ajay K Khera
(AK)
Sanjay Kinra
(S)
Parvaiz A Koul
(PA)
Varsha Krish
(V)
Rinu P Krishnankutty
(RP)
Anura V Kurpad
(AV)
Hmwe H Kyu
(HH)
Avula Laxmaiah
(A)
Jagadish Mahanta
(J)
P A Mahesh
(PA)
Ridhima Malhotra
(R)
Raja S Mamidi
(RS)
Helena Manguerra
(H)
Joseph L Mathew
(JL)
Manu R Mathur
(MR)
Ravi Mehrotra
(R)
Satinath Mukhopadhyay
(S)
G V S Murthy
(GVS)
Parul Mutreja
(P)
Balakrishna Nagalla
(B)
Grant Nguyen
(G)
Anu M Oommen
(AM)
Ashalata Pati
(A)
Sanghamitra Pati
(S)
Samantha Perkins
(S)
Sanjay Prakash
(S)
Manorama Purwar
(M)
Rajesh Sagar
(R)
Mari J Sankar
(MJ)
Deepika S Saraf
(DS)
D K Shukla
(DK)
Sharvari R Shukla
(SR)
Narinder P Singh
(NP)
V Sreenivas
(V)
Babasaheb Tandale
(B)
Kavumpurathu R Thankappan
(KR)
Manjari Tripathi
(M)
Suryakant Tripathi
(S)
Srikanth Tripathy
(S)
Christopher Troeger
(C)
Chris M Varghese
(CM)
Santosh Varughese
(S)
Stefanie Watson
(S)
Geetika Yadav
(G)
Sanjay Zodpey
(S)
K Srinath Reddy
(KS)
G S Toteja
(GS)
Mohsen Naghavi
(M)
Stephen S Lim
(SS)
Theo Vos
(T)
Hendrik J Bekedam
(HJ)
Soumya Swaminathan
(S)
Christopher J L Murray
(CJL)
Simon I Hay
(SI)
R S Sharma
(RS)
Lalit Dandona
(L)
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products, or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.
Références
Bull World Health Organ. 2019 Apr 1;97(4):270-282
pubmed: 30940984
BMJ Open. 2016 Aug 05;6(8):e009885
pubmed: 27496225
Lancet. 2018 Nov 10;392(10159):2091-2138
pubmed: 30496107
Health Policy Plan. 2017 Feb;32(1):79-90
pubmed: 27515405
BMC Health Serv Res. 2016 Jul 07;16:225
pubmed: 27387920
Health Policy Plan. 2002 Mar;17(1):90-8
pubmed: 11861590
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
BMC Med. 2019 Jul 19;17(1):140
pubmed: 31319860
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
Int J Equity Health. 2017 Mar 7;16(1):46
pubmed: 28270151
Lancet. 2016 Jan 16;387(10015):273-83
pubmed: 26510780
Lancet Planet Health. 2019 Jan;3(1):e26-e39
pubmed: 30528905
PLoS One. 2018 Jul 30;13(7):e0201125
pubmed: 30059555
J Family Med Prim Care. 2015 Apr-Jun;4(2):251-6
pubmed: 25949976
Soc Sci Med. 2006 May;62(9):2205-15
pubmed: 16330139
Lancet. 2012 Jun 9;379(9832):2162-72
pubmed: 22682464
Lancet. 2014 Jul 26;384(9940):347-70
pubmed: 24853604
Lancet. 2017 Oct 28;390(10106):1972-1980
pubmed: 28939096
Lancet. 2011 Jan 22;377(9762):332-49
pubmed: 21227494
PLoS One. 2013 May 22;8(5):e64126
pubmed: 23717547
Lancet. 2017 Sep 16;390(10100):1084-1150
pubmed: 28919115
Lancet. 2015 May 2;385(9979):1767-1776
pubmed: 25842221
Nature. 2018 Feb 28;555(7694):41-47
pubmed: 29493591
Lancet Glob Health. 2018 Nov;6(11):e1186-e1195
pubmed: 30322649
BMC Health Serv Res. 2017 May 19;17(1):360
pubmed: 28526027
Lancet Child Adolesc Health. 2019 Dec;3(12):855-870
pubmed: 31542357
Lancet Glob Health. 2019 Jun;7(6):e721-e734
pubmed: 31097276
Lancet. 2017 Nov 11;390(10108):2171-2182
pubmed: 28958464
J Public Health (Oxf). 2013 Dec;35(4):598-606
pubmed: 23359666
BMJ Open. 2015 May 11;5(5):e007589
pubmed: 25968003
Int Health. 2019 Sep 2;11(5):344-348
pubmed: 31529108
Glob Health Action. 2014 Dec 03;7:24939
pubmed: 25476929
Nature. 2019 Oct;574(7778):353-358
pubmed: 31619795
Sci Data. 2017 Jan 31;4:170001
pubmed: 28140386
Lancet Glob Health. 2018 Nov;6(11):e1144-e1145
pubmed: 30196091
Int J Equity Health. 2017 Mar 10;16(1):48
pubmed: 28283045
J Clin Diagn Res. 2016 Jun;10(6):LC07-9
pubmed: 27504314
BMC Public Health. 2011 Apr 13;11 Suppl 3:S10
pubmed: 21501427
Indian J Community Med. 2018 Jul-Sep;43(3):148-152
pubmed: 30294077
Lancet. 2014 Jul 12;384(9938):189-205
pubmed: 24853593
BMC Public Health. 2011 Apr 13;11 Suppl 3:S12
pubmed: 21501429
Lancet. 2018 Nov 17;392(10160):2203-2212
pubmed: 30195398
BMC Health Serv Res. 2018 Apr 12;18(1):281
pubmed: 29650002
Lancet. 2017 Dec 2;390(10111):2437-2460
pubmed: 29150201
J Epidemiol Glob Health. 2012 Dec;2(4):221-4
pubmed: 23856504
Lancet. 2016 Dec 3;388(10061):2811-2824
pubmed: 27072119
Lancet Glob Health. 2013 Oct;1(4):e219-26
pubmed: 25104347
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Lancet. 2013 Sep 21;382(9897):1029-38
pubmed: 24054534
Lancet. 2018 Nov 10;392(10159):1923-1994
pubmed: 30496105
PLoS One. 2011;6(11):e26856
pubmed: 22073208
Matern Child Health J. 2015 Aug;19(8):1853-63
pubmed: 25656720
J Child Health Care. 2013 Dec;17(4):397-409
pubmed: 23435164
PLoS One. 2012;7(5):e37515
pubmed: 22629412
Lancet. 2010 Jun 5;375(9730):2009-23
pubmed: 20569841
PLoS Med. 2018 Oct 31;15(10):e1002687
pubmed: 30379812
BMC Pregnancy Childbirth. 2016 May 18;16(1):116
pubmed: 27193837